Prison TB study tests shorter prevention course

NCT ID NCT03089983

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at ways to prevent tuberculosis (TB) in Malaysian prisoners, many of whom also had HIV, opioid addiction, or hepatitis. Researchers compared a standard 40-week TB prevention treatment with a shorter 12-week option. The goal was to see which approach worked better in a prison setting and to model cost-effective strategies for TB screening and treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

isoniazid and rifapentine

What this could lead to

If successful, this could point toward more effective and shorter TB prevention strategies for high-risk prison populations.

What could go wrong

This is an observational and comparative study, not a large-scale trial. Results may not apply to other settings or populations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS Behavior, Addictive hepatitis HIV infectious disease latent tuberculosis infection opiate dependence tuberculosis active tuberculosis prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kajang Prison

    Kajang, Selangor, Malaysia